Skip to main content
. 2021 Apr 27;11:9016. doi: 10.1038/s41598-021-88512-0

Figure 5.

Figure 5

Figure 5

Nek2 is required for invasion and migration in triple-negative breast cancer cells. (a–d) Invasion and migration of MDA-MB-231 cells treated with siNek2 (a) and (b) or INH6 (c) and (d). (e–f) Invasion and migration of Hs578t treated with siNek2. (g,h) CCK8 cell proliferation assay was assessed in MDA-MB-231 using siNek2 (g) or INH6 (h). Data represent mean fold change ± SEM of three independent experiments.